NFKB1 and osteoarthritis: Isoliensinine demonstrates anti-inflammatory and chondroprotective effects in osteoarthritis by reducing extracellular matrix degradation, NLRP3 activation, and Matrix metalloproteinase 3 (MMP-3) expression while inhibiting MAPK/NF-κB signaling and chondrocyte pyroptosis [68].